Skip to main content
. 2024 Feb 29;36(1):90–102. doi: 10.21147/j.issn.1000-9604.2024.01.09

Figure 4.

Figure 4

Survival plots of targetable patients with target therapy and non-targetable patients with other therapies. (A) PFS of patients with/without target therapy (P=0.006); (B) OS of patients with/without target therapy (P=0.020). PFS, progression-free survival; OS, overall survival.